Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose:The phenotypic manifestations of cerebral cavernous malformation disease caused by rare PDCD10 mutations have not been systematically examined, and a mechanistic link to Rho kinase–mediated hyperpermeability, a potential therapeutic target, has not been established.Methods:We analyzed PDCD10 small interfering RNA–treated endothelial cells for stress fibers, Rho kinase activity, and permeability. Rho kinase activity was assessed in cerebral cavernous malformation lesions. Brain permeability and cerebral cavernous malformation lesion burden were quantified, and clinical manifestations were assessed in prospectively enrolled subjects with PDCD10 mutations.Results:We determined that PDCD10 protein suppresses endothelial stress fibers, Rho kinase activity, and permeability in vitro. Pdcd10 heterozygous mice have greater lesion burden than other Ccm genotypes. We demonstrated robust Rho kinase activity in murine and human cerebral cavernous malformation vasculature and increased brain vascular permeability in humans with PDCD10 mutation. Clinical phenotype is exceptionally aggressive compared with the more common KRIT1 and CCM2 familial and sporadic cerebral cavernous malformation, with greater lesion burden and more frequent hemorrhages earlier in life. We first report other phenotypic features, including scoliosis, cognitive disability, and skin lesions, unrelated to lesion burden or bleeding.Conclusion:These findings define a unique cerebral cavernous malformation disease with exceptional aggressiveness, and they inform preclinical therapeutic testing, clinical counseling, and the design of trials.Genet Med 17 3, 188–196.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of familial cavernous malformations: results of an ongoing study
Zabramski, J. M., Wascher, T. M., Spetzler, R. F., Johnson, B., Golfinos, J., Drayer, B. P., Brown, B., Rigamonti, D., & Brown, G. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.3.0422 · Cited by 997
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Zhou, Q., & Liao, J. K. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0110 · Cited by 567
EndMT contributes to the onset and progression of cerebral cavernous malformations
Maddaluno, L., Rudini, N., Cuttano, R., Bravi, L., Giampietro, C., Corada, M., Ferrarini, L., Orsenigo, F., Papa, E., Boulday, G., et al. (2013) · Nature · doi:10.1038/nature12207 · Cited by 486
Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations
Bergametti, F., Denier, C., Labauge, P., Arnoult, M., Boetto, S., Clanet, M., Coubes, P., Echenne, B., Ibrahim, R., Irthum, B., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/426952 · Cited by 450
Age-Related Intimal Stiffening Enhances Endothelial Permeability and Leukocyte Transmigration
Huynh, J., Nishimura, N., Rana, K., Peloquin, J. M., Califano, J. P., Montague, C. R., King, M. R., Schaffer, C. B., & Reinhart-King, C. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002761 · Cited by 402
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
Whitehead, K. J., Chan, A. C., Navankasattusas, S., Koh, W., London, N. R., Ling, J., Mayo, A. H., Drakos, S. G., Jones, C. A., Zhu, W., et al. (2009) · Nature Medicine · doi:10.1038/nm.1911 · Cited by 377
Self-citationIntracranial Cavernous Malformations
Maraire, J. N., & Awad, I. A. (1995) · Neurosurgery · doi:10.1227/00006123-199510000-00001 · Cited by 360
Self-citationCerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
Stockton, R. A., Shenkar, R., Awad, I. A., & Ginsberg, M. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091258 · Cited by 351
Self-citationSalman, R. A.-S., Hall, J. M., Horne, M. A., Moultrie, F., Josephson, C. B., Bhattacharya, J. J., Counsell, C. E., Murray, G. D., Papanastassiou, V., Ritchie, V., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70004-2 · Cited by 308
The natural history of intracranial cavernous malformations
Gross, B. A., Lin, N., Du, R., & Day, A. L. (2011) · Neurosurgical Focus · doi:10.3171/2011.3.focus1165 · Cited by 306
Hemorrhage From Cavernous Malformations of the Brain: Definition and Reporting Standards
Al-Shahi Salman, R., Berg, M. J., Morrison, L., & Awad, I. A. (2008) · Stroke · doi:10.1161/strokeaha.108.515544 · Cited by 302
Self-citationAkers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M., & Marchuk, D. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn430 · Cited by 292
Self-citationGenotype–phenotype correlations in cerebral cavernous malformations patients
Denier, C., Labauge, P., Bergametti, F., Marchelli, F., Riant, F., Arnoult, M., Maciazek, J., Vicaut, E., Brunereau, L., & Tournier‐Lasserve, E. (2006) · Annals of Neurology · doi:10.1002/ana.20947 · Cited by 269
Grassie, M. E., Moffat, L. D., Walsh, M. P., & MacDonald, J. A. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.01.018 · Cited by 236
STRIPAK complexes: Structure, biological function, and involvement in human diseases
Hwang, J., & Pallas, D. C. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.11.021 · Cited by 231
Gault, J., Shenkar, R., Recksiek, P., & Awad, I. A. (2005) · Stroke · doi:10.1161/01.str.0000157586.20479.fd · Cited by 157
Self-citationFasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease
McDonald, D. A., Shi, C., Shenkar, R., Stockton, R. A., Liu, F., Ginsberg, M. H., Marchuk, D. A., & Awad, I. A. (2011) · Stroke · doi:10.1161/strokeaha.111.625467 · Cited by 151 · cited 1×
“Journal Genetics in medicine : official journal of the American College of Medical Genetics, 17(3)”
Self-citationMurányi, A., Derkach, D. N., Erdődi, F., Kiss, A., Ito, M., & Hartshorne, D. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.055 · Cited by 148
Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice
Chan, A. C., Drakos, S. G., Ruiz, O. E., Smith, A. C. H., Gibson, C. C., Ling, J., Passi, S. F., Stratman, A. N., Sacharidou, A., Revelo, M. P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44393 · Cited by 145
Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype
Borikova, A. L., Dibble, C. F., Sciaky, N., Welch, C. M., Abell, A. N., Bencharit, S., & Johnson, G. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.097220 · Cited by 142
McDonald, D. A., Shenkar, R., Shi, C., Stockton, R. A., Akers, A. L., Kucherlapati, M. H., Kucherlapati, R., Brainer, J., Ginsberg, M. H., Awad, I. A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq433 · Cited by 132
Self-citationCCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation
Fidalgo, M., Fraile, M., Pires, A., Force, T., Pombo, C., & Zalvide, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.061341 · Cited by 128
Plummer, N. W., Gallione, C. J., Srinivasan, S., Zawistowski, J. S., Louis, D. N., & Marchuk, D. A. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63409-8 · Cited by 125
Self-citationLoss of cerebral cavernous malformation 3 ( Ccm3 ) in neuroglia leads to CCM and vascular pathology
Louvi, A., Chen, L., Two, A. M., Zhang, H., Wang, M., & Günel, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012617108 · Cited by 108
You, C., Sandalcioglu, I. E., Dammann, P. R., Felbor, U., Sure, U., & Zhu, Y. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12022 · Cited by 104
Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease
Yoruk, B., Gillers, B. S., Chi, N. C., & Scott, I. C. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2011.12.006 · Cited by 95
de Champfleur, N. M., Langlois, C., Ankenbrandt, W. J., Bars, E. L., Leroy, M. A., Duffau, H., Bonafé, A., Jaffe, J., Awad, I. A., & Labauge, P. M. (2010) · Neurosurgery · doi:10.1227/neu.0b013e31820773cf · Cited by 94
Self-citationLarsson, H. B. W., Hansen, A. E., Berg, H. K., Rostrup, E., & Haraldseth, O. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21328 · Cited by 82
Fisher, O. S., & Boggon, T. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1532-9 · Cited by 76
Ceccarelli, D. F., Laister, R. C., Mulligan, V. K., Kean, M. J., Goudreault, M., Scott, I. C., Derry, W. B., Chakrabartty, A., Gingras, A.-C., & Sicheri, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213777 · Cited by 74
Zhang, Y., Tang, W., Zhang, H., Niu, X., Xu, Y., Zhang, J., Gao, K., Pan, W., Boggon, T. J., Toomre, D. K., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.09.021 · Cited by 68
D’Angelo, R., Marini, V., Rinaldi, C., Origone, P., Dorcaratto, A., Avolio, M., Goitre, L., Forni, M., Capra, V., Alafaci, C., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00441.x · Cited by 64
A Method for Measuring Rho Kinase Activity in Tissues and Cells
Liu, P., & Liao, J. K. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)00414-4 · Cited by 64
Evaluating Strategies for the Treatment of Cerebral Cavernous Malformations
Li, D. Y., & Whitehead, K. J. (2010) · Stroke · doi:10.1161/strokeaha.110.594929 · Cited by 63
Shenkar, R., Venkatasubramanian, P. N., Wyrwicz, A. M., Zhao, J.-C., Shi, C., Akers, A. L., Marchuk, D. A., & Awad, I. A. (2008) · Neurosurgery · doi:10.1227/01.neu.0000315862.24920.49 · Cited by 54
Self-citationGenetic and cellular basis of cerebral cavernous malformations: implications for clinical management
Bacigaluppi, S., Retta, S. F., Pileggi, S., Fontanella, M. M., Goitre, L., Tassi, L., Camera, A. L., Citterio, A., Patrosso, M., Tredici, G., et al. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01892.x · Cited by 39
Ccm3 , a gene associated with cerebral cavernous malformations, is required for neuronal migration
Louvi, A., Nishimura, S., & Günel, M. (2014) · Development · doi:10.1242/dev.093526 · Cited by 35
Cited by
Akers, A., Al-Shahi Salman, R., A. Awad, I., Dahlem, K., Flemming, K., Hart, B., Kim, H., Jusue-Torres, I., Kondziolka, D., Lee, C., et al. (2017) · Neurosurgery · doi:10.1093/neuros/nyx091 · Cited by 495
Self-citation
Metadata
- Authors
- Shenkar, R., Shi, C., Rebeiz, T., Stockton, R. A., McDonald, D. A., Mikati, A. G., Zhang, L., Austin, C., Akers, A. L., Gallione, C. J., Rorrer, A., Gunel, M., Min, W., Marcondes de Souza, J., Lee, C., Marchuk, D. A., & Awad, I. A.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 17
- Issue
- 3
- Pages
- 188-196
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2004220217
- Cited by
- 163
- References
- 37
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.